Clearview Wealth Advisors LLC Moderna, Inc. Transaction History

Clearview Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$118.38 - $210.04 $14,205 - $25,204	-120 Reduced 96.0%	5 $0
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $225 - $368	-1 Reduced 0.79%	125 $32,000
Q3 2021 Nov 02, 2021	SELL	$221.9 - $484.47 $41,051 - $89,626	-185 Reduced 59.49%	126 $48,000
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $545 - $929	5 Added 1.63%	311 $41,000
Q4 2020 Jan 21, 2021	BUY	$65.74 - $169.86 $20,116 - $51,977	306 New	306 $32,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.